US stock market unusual movement | Wells Fargo & Co lowered the target price to $9, Editas Medicine (EDIT.US) fell more than 2%.

Zhitong Finance · Oct 23 22:39 · Ratings

On Wednesday, shares of Editas Medicine (EDIT.US) fell, down 2.58% as of press time, to $3.205.

According to the AI Financial APP, on Wednesday, shares of Editas Medicine (EDIT.US) fell, down 2.58% as of press time, to $3.205. On the news side, wells fargo & co analyst Yanan Zhu maintained an equal weight rating for Editas Medicine and lowered the target price from $27 to $9.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

美股异动 | 富国银行下调目标价至9美元 Editas Medicine(EDIT.US)跌逾2%

US stock market unusual movement | Wells Fargo & Co lowered the target price to $9, Editas Medicine (EDIT.US) fell more than 2%.

Risk Disclaimer

Statement